BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 32883279)

  • 1. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.
    Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A
    BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program.
    Thankappan KR; Sathish T; Tapp RJ; Shaw JE; Lotfaliany M; Wolfe R; Absetz P; Mathews E; Aziz Z; Williams ED; Fisher EB; Zimmet PZ; Mahal A; Balachandran S; D'Esposito F; Sajeev P; Thomas E; Oldenburg B
    PLoS Med; 2018 Jun; 15(6):e1002575. PubMed ID: 29874236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala diabetes prevention program (K-DPP).
    Mathews E; Thomas E; Absetz P; D'Esposito F; Aziz Z; Balachandran S; Daivadanam M; Thankappan KR; Oldenburg B
    BMC Public Health; 2018 Jan; 17(1):974. PubMed ID: 29298703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A group-based lifestyle intervention for diabetes prevention in low- and middle-income country: implementation evaluation of the Kerala Diabetes Prevention Program.
    Aziz Z; Mathews E; Absetz P; Sathish T; Oldroyd J; Balachandran S; Shetty SS; Thankappan KR; Oldenburg B
    Implement Sci; 2018 Jul; 13(1):97. PubMed ID: 30021592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a lifestyle intervention on cardiovascular risk among high-risk individuals for diabetes in a low- and middle-income setting: Secondary analysis of the Kerala Diabetes Prevention Program.
    Lotfaliany M; Sathish T; Shaw J; Thomas E; Tapp RJ; Kapoor N; Thankappan KR; Oldenburg B
    Prev Med; 2020 Oct; 139():106068. PubMed ID: 32194098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India.
    Islek D; Weber MB; Ranjit Mohan A; Mohan V; Staimez LR; Harish R; Narayan KMV; Laxy M; Ali MK
    JAMA Netw Open; 2020 Jul; 3(7):e207539. PubMed ID: 32725244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cluster randomised controlled trial of a peer-led lifestyle intervention program: study protocol for the Kerala diabetes prevention program.
    Sathish T; Williams ED; Pasricha N; Absetz P; Lorgelly P; Wolfe R; Mathews E; Aziz Z; Thankappan KR; Zimmet P; Fisher E; Tapp R; Hollingsworth B; Mahal A; Shaw J; Jolley D; Daivadanam M; Oldenburg B
    BMC Public Health; 2013 Nov; 13():1035. PubMed ID: 24180316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.
    Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.
    Png ME; Yoong JS
    PLoS One; 2014; 9(9):e107225. PubMed ID: 25203633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial.
    Duijzer G; Bukman AJ; Meints-Groenveld A; Haveman-Nies A; Jansen SC; Heinrich J; Hiddink GJ; Feskens EJM; de Wit GA
    BMC Health Serv Res; 2019 Nov; 19(1):824. PubMed ID: 31711499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Three Doses of a Behavioral Intervention to Prevent or Delay Type 2 Diabetes in Rural Areas.
    Radcliff TA; Côté MJ; Whittington MD; Daniels MJ; Bobroff LB; Janicke DM; Perri MG
    J Acad Nutr Diet; 2020 Jul; 120(7):1163-1171. PubMed ID: 31899170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM; Schlessinger L; Kahn R
    Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of a Comprehensive Approach for Hypertension Control in Low-Income Settings in Argentina: Trial-Based Analysis of the Hypertension Control Program in Argentina.
    Augustovski F; Chaparro M; Palacios A; Shi L; Beratarrechea A; Irazola V; Rubinstein A; Mills K; He J; Pichon Riviere A
    Value Health; 2018 Dec; 21(12):1357-1364. PubMed ID: 30502778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
    Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
    J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact.
    Laxy M; Zhang P; Ng BP; Shao H; Ali MK; Albright A; Gregg EW
    Appl Health Econ Health Policy; 2020 Oct; 18(5):713-726. PubMed ID: 32607728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial.
    van Wier MF; Lakerveld J; Bot SD; Chinapaw MJ; Nijpels G; van Tulder MW
    BMC Fam Pract; 2013 Apr; 14():45. PubMed ID: 23557482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complaint-Directed Mini-Interventions for Depressive Symptoms: A Health Economic Evaluation of Unguided Web-Based Self-Help Interventions Based on a Randomized Controlled Trial.
    Wijnen BF; Lokman S; Leone S; Evers SM; Smit F
    J Med Internet Res; 2018 Oct; 20(10):e10455. PubMed ID: 30274958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A culturally adapted lifestyle intervention addressing a Middle Eastern immigrant population at risk of diabetes, the MEDIM (impact of Migration and Ethnicity on Diabetes In Malmö): study protocol for a randomized controlled trial.
    Saha S; Leijon M; Gerdtham U; Sundquist K; Sundquist J; Arvidsson D; Bennet L
    Trials; 2013 Sep; 14():279. PubMed ID: 24006857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.